Bilcare GCS Capabilities Presentation 2009 Printable
Transcript of Bilcare GCS Capabilities Presentation 2009 Printable
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
1/54
Service and Quality Beyond Compliance
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
2/54
An international organization providing the
worldwide pharmaceutical industry withexcellence in formulation development, clinicalmanufacturing, analytical support, packaging and
global distribution of clinical trial supplies.
Our Vision: Transforming Health Outcomes Touching Lives
Our Values: Speed. Innovation. Happiness.
Bilcare GCS Overview
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
3/54
INNOVATION
TRUST
COMMITMENT AND FACE
Delivery BeyondCompliance
Project Mgmt
Contract Mgmt
Integrated
Quality
Assurance
System
Integration
Technology
Optima
Blister Pack
Design
Global Labeling
System
IVRS Next-Gen
Compliance
Why Bilcare GCS?
Flexibility
IN-Sourcing
Geographic
Locations
Quantity /
Capacity
Speed of
Turnaround
Knowledge
One Stop Shop
for Clinical
Supplies
Deep Customer
Knowledge and
Relationship
Focus
Experience
Unique
India Research
Academy
Dedicated India
Campus
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
4/54
Bilcare History
2008
1982 Bilcare Founded, Pune India
2002 Singapore Facility Begins Operations
2005 Bilcare GCS Americas Clinical Supplies Facility Acquired
2006 Bilcare GCS Europe Clinical Supplies Facility Acquired
2007 Bilcare Research Academy Establishes Alliance with
the Association of Clinical Research Professionals (ACRP)
2005 Bilcare GCS Asia (India) Clinical Supplies Facility Complete
Bilcare GCS Americas Completes Packaging Suites; ExpandsPhase III Manufacturing Capabilities
Bilcare GCS Asia (India) Completes Logistics and LabelOperations Expansions
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
5/54
Bilcare GCS Global Facilities
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
6/54
Bilcare GCS Americas
Locations
300 Kimberton Rd. Phoenixville, PA 19460
1041 W. Bridge St. Phoenixville, PA 19460
DEA Licensed for Controlled Substances
FDA Registered Facility
Facilities
26 Production Suites Total
Kimberton Rd.Administrative Offices
10 Primary and 12 Secondary Production Suites
Warehouse
W. Bridge St.Administrative Offices
4 Secondary Production Suites
Warehouse
Global Facilities Americas
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
7/54
Bilcare GCS Europe
Location
Waller House
Elvicta Business Park
Crickhowell, Powys NP8 1DF
Wales, UK
MHRA Licensed Facility
Facilities
14 Production Suites Total
Couzens BuildingAdministrative Offices
Production Suite 4 Suites (Primary/Secondary)
Waller HouseAdministrative Offices
Production Suite 10 Suites (Primary/Secondary)
Warehouse
Global Facilities Europe
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
8/54
Expansion: Bilcare GCS Europe
Expansion 2009Storage and Distribution
Secure Drug Storage & Returns,Ambient / CRT / Refrigerated / Frozen
Yielding 1,000 Additional Pallet Locations Control Substances Secure Vaults
Secure Warehousing Bulk and CriticalComponents
Global Facilities Europe
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
9/54
Bilcare GCS Asia India
Location
307,1028 Shiroli,
Rajgurunagar, Pune 411030
India 125 Acre Campus
Licensed for Controlled Substances
Facilities
11 Production Suites Total Administrative Offices
4 Primary and 7 SecondaryProduction Suites
Warehouse
Global Facilities AsiaIndia Facility
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
10/54
Expanded Capabilities
Bilcare GCS Asia India
Operations
New Label Control Facilities
Storage and Distribution
Control Substances Secure Vaults
Secure Warehousing Bulk and CriticalComponents
Secure Drug Storage, Ambient / CRT /Refrigerated / Frozen
Greater Asia Logistics Operations
Global Facilities AsiaIndia Facility
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
11/54
Bilcare GCS Asia Singapore
Location
52, Changi South Street 1
Singapore 486161
GMP Certified Facility
Highest Standard Facility in Asia
Facilities
Administrative Offices 2 Secondary Production Suites
Warehouse
Global Facilities AsiaSingapore Facility
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
12/54
Bilcare GCS Global Capabilities
Clinical
Research &
Development
Clinical
Manufacturing
Packaging &
Labeling
Global
Logistics &
Supply
Chain
Management
IVRS
IWRS
Global
Comparator
Sourcing
IN-Sourcing
Offsite
Clinical
Supplies
Operations
Project Management
Quality Foundation & Services
You
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
13/54
Global Capabilities Project Management
Bilcare
EuropeProject
Management
Bilcare
N. AmericaProject
Management
BilcareAsia
ProjectManagement
BilcareStrategic
Management
You
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
14/54
Global Capabilities Project Management
Bilcare GCSProject
Management
ProactiveCommunication
GlobalExperience
Continuous
Training
Functional
Expertise
LessonsLearned
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
15/54
Communication Customized Communication Plan
Kick-Off Meetings
Team Meetings
Measuring Success Overall Performance
On-time Production
On-time Shipments and Logistics Processing of Import/Export Materials and
Supplies
Evaluation of Bilcare Locations in General andSpecific Functions
Gantt Charts
Global Capabilities Project Management
Dedicated Project Management Globally and Site Specific (Bilcare Locations)
Label Control Teams
Logistics Teams
Lessons Learned Review of Goals Reached & Attempted
Review of Metrics in Reaching Goals -Performance
Evaluation of Communication
Gantt Charts
Bilcare GCS Project ManagementThe Key to Your Projects Success
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
16/54
Global Capabilities Clinical R&D
FormulationDevelopment
AnalyticalServices
ClinicalResearch &
Development
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
17/54
Bilcare GCS Analytical ServicesGMP qualified scientists oversee comprehensivetesting of your materials. We take extra steps toensure that your products comply with regulatorystandards.
Seven Analytical Laboratories
Spectroscopy Laboratory
Dissolution Laboratory
Chromatography Laboratory
Physical Testing Laboratory Sample Preparation Laboratory
Development Laboratories
Stability Storage Suite
Global Capabilities Analytical
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
18/54
Bilcare GCS Analytical ServicesOur dedicated personnel provide technical supportduring each phase of your products development
and manufacturing.
Analytical Laboratory Testing
HPLC Analysis
Content Uniformity Studies Chromatographic Impurity Profiling
Performance Type Testing (e.g. Friability, Hardness
and Dissolution Testing)
Identification Testing Release Testing
Stability and Storage Testing
Cleaning Verification / Validation
Global Capabilities Analytical
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
19/54
Bilcare GCS Analytical ServicesOur dedicated personnel provide technical supportduring each phase of your products development
and manufacturing.
Analytical Laboratory Testing (Continued)
Accelerated Drug Stressing
Dissolution Profile Testing Extractable Studies for Parenteral Products
Competitor Analysis for Unbiased De-Formulation
Hygroscopicity Studies
Method Development and Validation for All Phasesand All Components in Development of the following:
Drug Substance
Non-Compendial Excipients
Drug Product
Process Development Support
Global Capabilities Analytical
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
20/54
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
21/54
Bilcare GCS Analytical ServicesBilcare GCS Americas can be utilized to supportAnalytical Research and Development for both EU
and Asia facilities.
Global Capabilities Analytical
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Analytical & Research Services
Analytical Laboratory 1 Release Testing 2 Stability 2 2 Method Development 1 1 Cleaning Verification Controlled Substance Management 1 1
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Analytical & Research Services
Analytical Laboratory 1 Release Testing 2 Stability 2 2 Method Development 1 1 Cleaning Verification Controlled Substance Management 1 1
- Fully Supported 1 - Achieved with Support from Bilcare GCS Americas 2 - Achieved with Support from Bilcare GCS Americas or Local Third Party
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
22/54
Bilcare GCS Formulation DevelopmentThe Bilcare team of formulation specialists is alwaysready to provide you with expeditious innovativeformulations for your clinical trials.
Pre-Formulation Services
Chemical Compatibility & Reactivity to Packaging Substrates
Physical Properties & Product Characterization
Accelerated Degradation
API-Excipient Interaction Studies
pKa Determination
Hygroscopicity Studies
Photostability of API
Prototype Evaluations
Reverse Engineering
Global Capabilities Formulation
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
23/54
Bilcare GCS Formulation DevelopmentFollowing the determination of the appropriatecomposition, the Bilcare formulation staff focus theirinterest on the development of the process for makingyour clinical trial material.
Formulation Development
Phase I-IV Formulation Development and Reformulations
Determine Blending Times for Tableting & Encapsulation and
Analysis of Characteristics (Blending Time, Bulk Density,
Content Uniformity, and Flow Characteristics)
Overencapsulation and Comparator Product Blinding
Develop Matching Placebo Product / Comparator Supplies
Develop Both Ethical and Over-The-Counter Products: tablets
(immediate and controlled release), powders, liquids,
suspensions, emulsions, creams and ointments, lotions Develop Line Extensions in the Above Dosage Forms
Global Capabilities Formulation
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
24/54
Bilcare GCS Formulation DevelopmentBilcare has the technical expertise, experience, andrange of technical support services to help you
achieve your clinical trial goals, troubleshoot existingproducts or improve current products.
Technical Services
Experienced Professionals to Troubleshoot Commercial
Products
Formulation Optimization & Evaluation of New Raw Materials
in Existing Products
Technical Transfer of Products from R&D to Production
Facilities
Process Optimization & Scale-up and Assessment of Current
Products & Recommendations for Improvements to Modernize
Existing Manufacturing / Clinical Supplies Processes
Global Capabilities Formulation
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
25/54
Bilcare GCS Formulation DevelopmentBilcare GCS Americas can be utilized to supportFormulation Development for both EU and Asia
facilities.
Global Capabilities Formulation
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Formulation Development 1 1 Controlled Substance Management
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Formulation Development 1 1 Controlled Substance Management
- Fully Supported 1 - Achieved with Support from Bilcare GCS Americas
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
26/54
Bilcare GCS Clinical ManufacturingOnce a drug has been formulated, Bilcare hasmanufacturing facilities that can provide fast, efficient
and agile manufacturing of solid dosage forms as wellas liquids, creams, and ointments.
Clinical Manufacturing Capabilities
Wet or Dry Granulation and Blending
Tablet Compression and Coating
Global Comparator Procurement
Manufacture Clinical Supplies
Blending and Encapsulation Encapsulation and Over-Encapsulation
Phase I-IV Development and Reformulations
Placebo Manufacturing
Comparator Blinding
Global Capabilities ClinicalManufacturing, Packaging & Labeling
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
27/54
Bilcare GCS Clinical ManufacturingOur unique approach enables us to support customerrequirements for short-term studies as well as large-
volume ongoing projects.
Dosage Forms Manufactured
Controlled and Immediate-Release Tablets
Capsules (Multi-Fill, Powder, Solid, Liquid, Semi-Solid,
Solid/Liquid Combination Fills)
Powders and Dry Powders
Liquids Suspensions
Emulsions
Creams & Ointments
Lotions
Global Capabilities ClinicalManufacturing, Packaging & Labeling
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
28/54
Bilcare GCS Clinical PackagingWe help you select the right packaging solutions,complete production and deliver a final product that
meets your high standards through comprehensivepackaging research that produces the best, customizedand innovative clinical packaging materials.
Primary and Secondary Packaging
Bottling (Solids / Semi-Solids)
Blister Packaging Any Configuration
Coldform & Thermoform
Blister Card Sealing and Walleting
Pouching / Powder Filling
Label Application and Kit Assembly
Controlled Substance Packaging (Schedule I V)
Ambient & Controlled Temp. (Refrigerated / Frozen) Packaging
Global Capabilities ClinicalManufacturing, Packaging & Labeling
Tube Filling
Creams
Ointments
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
29/54
Bilcare GCS Clinical LabelingBilcare provides support with full labeling services andinnovations for your product, meeting all of your high
standards and expectations. We pay strict attention toglobal regulatory requirements.
In-House Label Generation, Production
Label Types Produced
Single & Multi-Panel
Single & Multi-Lingual
Randomized & Open
Sequentially Numbered
Variable Text
32 Languages Fully Supported
Code Break & Randomization Generation
Client-Supplied Randomization Fully Supported 21 CFR Part 11 Compliant PRISYM Software for Label Design
Global Capabilities ClinicalManufacturing, Packaging & Labeling
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
30/54
Global Capabilities ClinicalManufacturing, Packaging & Labeling
The Bilcare GCS Integrated ProcessOur clinical manufacturing, packaging & labelingcapabilities fall under one powerful comprehensive pathin meeting all of your clinical project needs.
The Benefits
A Single Point of Contact
A Single Audit for You to Complete and Sustain
Single Format and Management of Batch Records and
Documentation
Minimized Manufacturing Timeline, Risk and Documentation
Delays that can Occur When Transferring Materials BetweenMultiple Vendor Strategies
Our Quality Process Ensures that We Have Produced:
The Right Product
In the Right Container
With the Correct Label
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
31/54
Bilcare GCS Clinical Manufacturing,Packaging & Labeling
Our global clinical services expertise supports
customers in every decision-making process.
Global Capabilities ClinicalManufacturing, Packaging & Labeling
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Clinical Manufacturing
Solid, Liquid, Creams 1 Encapsulation 1 Over-encapsulation 1 Controlled Substance Management 1
Packaging Bottling High Speed Bottling 2 2 Blistering High Speed Blistering 1 Pouching 1 Tube Filling 1 Blister Carding Label Application and Kit Assembly
Controlled Substance Management Comparator Sourcing & Acquisition
Labeling
Label design Label production Label procurement
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Clinical Manufacturing
Solid, Liquid, Creams 1 Encapsulation 1 Over-encapsulation 1 Controlled Substance Management 1
Packaging Bottling High Speed Bottling 2 2 Blistering High Speed Blistering 1 Pouching 1 Tube Filling 1 Blister Carding Label Application and Kit Assembly Controlled Substance Management Comparator Sourcing & Acquisition
Labeling
Label design Label production Label procurement
- Fully Supported 1 - Achieved with Support from Bilcare GCS Americas and/or Europe 2 - Achieved with Support from Bilcare GCS Americas
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
32/54
Bilcare GCS Global Logistics &Supply Chain ManagementBilcare can store and ship your materials to sitesworldwide under any array of conditions. You canrely on our proven global network to have the rightproduct to the right site under the right timeline.
Our Advantage
Customized Logistics Solutions Import / Export of Clinical Trial Material
Depot Management
Conditions Supported: Ambient, Refrigerated
(2-8C) & Frozen (-20C, -70C, -80C)
Cold Chain Solutions
Global Distribution Management
Specialized Logistics Project Management Controlled Substance Management
Global Capabilities Logistics &Supply Chain Management
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
33/54
Bilcare GCS Global Logistics &Supply Chain ManagementIn addition to our vast global storage & distributioncapabilities, we provide reconciliation anddestruction services for returned goods withoptimal accuracy and efficiency.
Returns & Destruction Customer and Project Specific Returns and
Reconciliation Protocols
Ample and Secured Storage
Regulatory Compliance and Documentation
Support
Updated and Complete Documentation on
Destruction
Global Capabilities Logistics &Supply Chain Management
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
34/54
Global Supply Chain Depot Network
Global Capabilities Logistics &Supply Chain Management
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
35/54
Bilcare GCS Global Logistics &Supply Chain ManagementThere are many smart reasons for using BilcareGlobal Logistics services to achieve success inyour clinical trials needs.
Global Capabilities Logistics &Supply Chain Management
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Global Logistics & Distribution Cold Chain Shipping Ambient (15-25
C)
Refrigerated (2-8C)
Frozen (-20C)
Deep Freeze (-70
C/-80
C)
Inventory Management Returns & Destruction Controlled Substance Management
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Global Logistics & Distribution Cold Chain Shipping Ambient (15-25
C)
Refrigerated (2-8C)
Frozen (-20C)
Deep Freeze (-70
C/-80
C)
Inventory Management Returns & Destruction Controlled Substance Management
- Fully Supported
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
36/54
Bilcare GCS IVR / IWR ServicesThere are a number of compelling benefits for using theBilcare GCS IVRS/IWRS for a more streamlined andsuccessful clinical trial.
Primary Benefits
24 Hours a Day / 7 Days a Week
Streamlined Setup and Validation of New Studies
Accelerated Process for Moving from Protocol to
User Acceptance Testing (UAT)
Extensive Experience and GuidanceSystem Flexibility
Use Statistical Scheme
Balance at Any Level
Can Accommodate Stratifications
Global Capabilities IVR / IWR Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
37/54
Bilcare GCS IVR / IWR ServicesPart of the Bilcare GCS Clinical Supply Chain is anInteractive Voice/Web Response System.
Access via Phone or Web
User Friendly and Easy to Use
Data Entry Direct from Source Toll-Free Phone Lines
Secure Entry
Available 24/7
Multilingual
Global Capabilities IVR / IWR Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
38/54
Bilcare GCS IVR / IWR ServicesThere are a number of compelling benefits for using theBilcare GCS IVRS/IWRS for a more streamlined andsuccessful clinical trial.
Automated System
Automates Patient Enrollment and Randomization
Captures Data
E-Diaries
Tracks Clinical Supplies Inventory and
Automatically Re-Supplies Clinical Trial Materials Ensures No Interruptions to Enrollment Due to
Clinical Supplies Problems
Streamlined Setup and Validation of New Studies
Accelerated Process for Moving from Protocol to
User Acceptance Testing (UAT)
Global Capabilities IVR / IWR Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
39/54
Bilcare GCS IVR / IWR ServicesBilcare GCS system is fully customizable and flexible toensure that all of your clinical trial needs are metwithout any interruption.
Study Material Management
At Warehouse
At Depots
At Sites
Individual Patient Assignments
Shipments
Phone or Web Management Site Initiation
Patient Enrollment
Randomization Drug Management
Global Capabilities IVR / IWR Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
40/54
Why Bilcare GCS IVR / IWR Services?
World-class speed for setup and validation ofnew studies less than four weeks from UserRequirement Specification (URS) approvals toUser Acceptance Testing (UAT)
Minimizes Per-Patient Cost of Trial Rapid Scale Out for New Sites, Dial-In Locations
(Point of Presence)
Easy to Validate, Easy to Purchase, and Easy to
Modify Ease of Access to Study Metrics
Extremely Flexible
Prevents Drug Wastage
Prevents Patient Over-Enrollment
Global Capabilities IVR / IWR Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
41/54
Bilcare GCS IVR / IWR ServicesBilcare GCS IVR / IWR services can be utilized tomanage any global study from any location.
Global Capabilities IVR / IWR Services
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
IVRS / IWRS
Design 1
1
Management 1 1
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
IVRS / IWRS
Design
1
1
Management 1 1
- Fully Supported 1 - Achieved with Support from Bilcare GCS Americas
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
42/54
Bilcare GCS Comparator SourcingProcurement of comparator drugs is often anextremely challenging aspect of implementingclinical studies. Because of Bilcare GCS globalpresence and experience, this aspect is achievedefficiently and effectively on a consistent basis.
Our Global Sourcing Network Supply Network
Drug Manufacturers Direct
Wholesalers
Established Relationships withManufacturers and Global Wholesalers
Market Agility: The Ability to Purchase Any
Product from Any Global Market
Your Confidentiality in Mind
Global Capabilities Comparator Sourcing
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
43/54
Bilcare GCS Comparator SourcingSince Bilcare GCS has facilities in North America,Europe, and Asia, procurement of comparatordrugs can be very efficiently implemented on yourcompanys behalf for studies around the world.
Global Capabilities Comparator Sourcing
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Comparator Sourcing
Comparator Sourcing Comparator Distribution Mgmt
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
Comparator Sourcing Comparator Sourcing Comparator Distribution Mgmt
- Fully Supported
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
44/54
Bilcare GCS Global IN-SourcingBilcare GCS major strength lies in its ability tofully integrate innovative solutions and services
throughout a drugs clinical trial life cycle Onsiteor Offsite. We bring all of our global expertise andexperience to you.
Clinical Supplies Operations at Your Site Staffing and Staff Augmentation
Operations / Production All Verticals
Complete Project Management
Quality / Regulatory Services
Full Accountability / Maximum Flexibility
The Bilcare GCS Promise Upheld: Service
and Quality Beyond Compliance Regardless of the Location of the Project
Global Capabilities IN-SourcingOffsite Clinical Supplies Operations
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
45/54
Bilcare GCS Global IN-SourcingBilcare GCS vision and values are carried with uswherever we operate. If your clinical trial needs
can not come to us, we can come to you to achievethe success that you are striving for in all of yourclinical supplies needs.
Global Capabilities IN-SourcingOffsite Clinical Supplies Operations
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
IN-Sourcing Offsite Clinical Supplies Ops.
Formulation Development Analytical & Research Services Clinical Manufacturing
Packaging
Labeling IVRS/IWRS Global Logistics & Distribution Quality Assurance Services
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
IN-Sourcing Offsite Clinical Supplies Ops.
Formulation Development Analytical & Research Services Clinical Manufacturing Packaging Labeling IVRS/IWRS Global Logistics & Distribution Quality Assurance Services
- Fully Supported
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
46/54
Bilcare GCS Quality FoundationBilcare GCS is registered with the DEA as aManufacturer, Distributor, Exporter, Importer and
Analytical Laboratory of Controlled Substances.
Regulatory HistoryBilcare GCS Americas
Establishment License (FDA) No 483s License 2531012
Last Inspection: January 2007
DEA Licensing No Citations / Issues
DEA Manufacturers License (I-V) RB0326923
DEA Distributor License (I-V) RB0326771
DEA Exporter License (I-V) RB0326810
DEA Importer License (IIIN, IV) RB0326822
DEA Analytical License (I-V) RB0326795 Last DEA Inspection: September 2006
Global Capabilities Quality Foundation & Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
47/54
Bilcare GCS Quality FoundationWe strive everyday to seek perfection in terms ofquality in the eyes of you (our client) and regulatory
agencies.
Regulatory History
Bilcare GCS Europe
MHRA Licensed Site Number 12225MHRA Audit March 3, 2008 No Critical or Major Observations
Manufacturers Authorization (Investigational Medicinal Products)
MA (IMP) 10284
6 named QPs
Manufacturers License (Assembly Only) AO/10284/1
Manufacturers Specials License MS/10284/1
Wholesale Dealers License WL/10284/1
Wholesale Dealers (Import) License WI/10284/1
Home Office Controlled Drugs Licenses
Global Capabilities Quality Foundation & Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
48/54
Bilcare GCS Quality FoundationOur Standard Operating Procedures (SOPs) can bemade available for your review during your audit of our
facilities. Feel free to schedule an audit or visit toBilcare soon.
Regulatory History
Bilcare GCS Asia
Controlled Substance License (Storage and Distribution)
Manufacturing License from State FDA
Storage & Distribution License from State FDA
NDPS I License from State FDA
Planned MHRA Inspection to Take Place Soon
Global Capabilities Quality Foundation & Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
49/54
Bilcare GCS Quality ServicesBilcare GCS offers QP Services in accordance withthe EU requirement that all investigational,
medicinal products manufactured or imported byorganizations holding a MA IMP have available aQualified Person to approve and release eachbatch of IMP for clinical trial use.
QP Services
Audit of Manufacturing Sites Within and
Outside the EU
Assessment of Each Batch for Certification
Prior to Release. May Include, as
appropriate:
Batch records, including control reports
In-process test reports and release reports
demonstrating compliance with the product
specification file, the order, protocol andrandomization code.
Global Capabilities Quality Foundation & Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
50/54
Bilcare GCS Quality ServicesQPs are assigned projects according to theirspecialized expertise and have personal and legal
responsibility as described in the EU Clinical TrialDirective (2001/20/EC) to ensure the investigationalproducts are produced in accordance with EUGMP and the clinical trial authority.
QP Services (Continued)
Production Conditions
The Validation Status of Facilities,
Processes & Methods
Examination of Finished Packs
Audit the Results of Any Analyses or Tests
Performed after Importation
Stability Reports
The Source and Verification of Conditions ofStorage and Shipment
Global Capabilities Quality Foundation & Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
51/54
Bilcare GCS Quality ServicesBilcare has a team of six Qualified Persons (QPs)with wide experience in the manufacture and
supply of Investigational Medicinal Products.QP Services (Continued)
Audit Reports Concerning the Quality System of
the Manufacturer
Documents Certifying that the Manufacturer isAuthorized to Manufacture Investigational
Medicinal Products or Comparators for Export by
the Appropriate Authorities in the Country of
Export
Regulatory Requirements for Marketing
Authorization, GMP Standards Applicable and Any
Official Verification of GMP Compliance
All Other Factors of Which the QP is Aware that
are Relevant to the Quality of the Batch Physical Examination of Packaging
Global Capabilities Quality Foundation & Services
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
52/54
Bilcare GCS Quality ServicesBilcare GCS Europe can be utilized to support QPServices for both Americas and Asia facilities.
Global Capabilities Quality Foundation & Services
GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
QP Services 1 1GLOBAL CAPABILITIES AMERICAS EUROPE ASIA
QP Services 1 1 - Fully Supported 1 - Achieved with Support from Bilcare GCS Europe
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
53/54
Assuring Success: The Next Steps
Your Strategic Alliance With Us
Bilcare GCS will facilitate your speed to market through utilization of vendor
capacity, flexibility and expertise; ultimately reducing fixed cost therebystrengthening your worldwide competitiveness.
The Next Steps Alliance Objective
Alliance Leadership
Integration Process
Realistic Potential
Commitment on Technology
Effective Governance Structure Communications Plan
Timeframe for Action
Internal and External Cross FunctionalCollaborations
-
8/7/2019 Bilcare GCS Capabilities Presentation 2009 Printable
54/54
We Look Forward to Meeting Your Needs!